# AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis

> **NCT00769028** · PHASE2 · UNKNOWN · sponsor: **Daval International Limited** · enrollment: 20 (estimated)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DRUG:** Hyperimmune caprine serum
- **DRUG:** Albumin

## Key facts

- **NCT ID:** NCT00769028
- **Lead sponsor:** Daval International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2011-02
- **Final completion:** 2011-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769028, "AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00769028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*